In the previous study focusing on colorectal cancer [14], two adhesion proteins (N-Cadherin and L1-CAM), known markers of the epithelial-to-mesenchymal transition [24], were investigated as potential future targets in cancer treatment. This evidence concerns the gene CDH2 and cancer.